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The aim of this study was to investigate the relationship 
between fetal acid-base status and fetal enzyme levels in 
umbilical cord blood. From October 1995 to 'January 1996, 
289 cases were recruited. Blood samples from the umbilical 
vein were collected for enzymes assay after delivery and before 
placental expulsion. The activities of fetal hepatic and cardiac 
enzymes were measured by automated techniques. 
Our results showed a positive skewness ill the 
distribu tion of alanine aminotransferase (AL T) , aspartate 
aminotransferase (AST) , glutamyltransferase (GGT) , creatine 
kinase (CK) and lactate dehydrogenase (LDH). The ranges 
demonstrated that levels of fetal AST, GGT, CK and LDH 
activities were much higher than in adults, except that ALT 
was lower. 
Relationships existed between cord blood neonatal 
enzymes and acid-base parameters. This correlation was 
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noted for AL T, AST, CK and LDH but did not apply to GGT. In 
grouped comparisons, only AST and LDH were shown to be 
significantly higher in the acidotic group than in the control. 
The fact that AST and LDH correlated strongly with fetal acid-
base status and were higher in the acidotic group suggested 
that it may be an early response to intrapartum hypoxia and 
acidosis. The close correlation between LDH and AST 
(R=O.5818) suggests that these two enzymes may be released 
through the same organ system or most probably by the same 
mechanism. 
In terms of mode of delivery, AST and LDH had 
significantly lower mean values ill the elective cesarean 
section group and were higher with vacuum extraction 
delivery. The higher levels of AST and LDH in the latter group 
may be due to either birth trauma or "fetal distress". 
Gamma glutamyltransferase activity in cord blood is 
correlated with gestational age, but not with fetal acid-base 
status, Apgar score or duration of labor. In the presence of 
2 
meconium stained liquor, GGT was significantly lower than in 
the control group, after adjusting for gestational age by 
regression analysis (P=O.O 1). Similarly, GGT levels in cord 
blood were lower in the vacuum extraction delivery group 
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Intrapartum asphyxia has long been recognized as a 
major contributor to neonatal morbidity, mortality and long-
term neurological sequelae. Despite the magnitude of its 
importance, there is no consensus agreement between 
professions regarding the defmition of birth asphyxia. To the 
obstetrician, meconium staining and abnormal fetal heart rate 
may be indicators of asphyxia. The neonatologist may 
consider that a depressed Apgar score and delay in 
establishing breathing defmes birth asphyxia. In Lackmann's 
study (1993), asphyxia was defined as Apgar score below 7 at 
5 and 10 minutes plus cord blood pH value below 7.10 and 
abnormal fetal heart rate pattern. Rivera and colleagues 
(1990) used the following defmitions for fetal stress: 
meconium passage in utero, fetal heart rate patterns showing 
decelerations, tight nuchal cord or difficult delivery. Fonseca 
and colleagues (1995) defmed perinatal asphyxia as abnormal 
fetal heart rate, scalp pH under 7.20 and Apgar score lower 
than 6 at 5 minutes of age. 
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Several studies have demonstrated that alanine 
aminotransferase (AL T), aspartate aminotransferase (AST) , y-
glutamyltransferase (GGT), creatine kinase (CK) and lactate 
dehydrogenase (LDH) activities rise in the serum of the 
infants in response to various pathological states, such as 
perinatal asphyxia, fetal hypoxia or trauma. For example, in a 
study of 50 asphyxiated infants, during the fIrst 72 hours of 
life there was a significant increase in the mean AST and AL T 
activities as compared to healthy neonates (Zanardo et al', 
1985). Lackmann and colleagues (1993) demonstrated that 
asphyxiated newborns had significantly increased serum 
activities of AST and LDH up to 72 hours post-partum. Rivera 
and associates (1990) reported that GGT activity in term 
infants with a history of perinatal stress was significantly 
higher than in infants without such history. Total CK was 
higher in umbilical venous blood from the asphyxiated 
newborns as compared to normal neonates (Fonseca et al, 
1995). These reports suggest that the activities of these 
enzymes could be used as markers of tissue damage. 
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The purpose of the current studies was to investigate 
the influence of fetal acid-base status on fetal enzyme levels in 
umbilical cord blood. Acid-base analysis of umbilical cord 
blood provides objective information on the acute and chronic 
respiratory and metabolic condition of the fetus at birth. 
Delivery per se, implying trauma or hypoxia, may influence 
enzyme levels. Therefore in our study we also examined the 
differences in the enzyme levels in umbilical cord blood in 
relation to the mode of delivery. 
The hypothesis is that fetal hypoxia can ' change the 
permeability of fetal cell membranes resulting in the release of 
the enzymes into the blood circulation, later detected as 




2.1 Basic concepts 
2. 1. 1 Enzyme activity and enzyme units 
Catalytic activity is defmed the more substrate and 
products that is converted under a standard conditions per 
unit of time, the higher is the enzyme activity. According to 
the Committee for Biochemical Nomenclature set up by the 
International Union of Pure and Applied Chemistry (IUPAC) 
and the International Union of Biochemistry (IUB), 1 }.lmol of 
substrate is changed by 1 enzyme unit (U) in 1 min. under 
standard conditions. The International Federation of Clinical 
Chemistry (IFCC) recommends the kataI (kat) as the basic 
unit of enzyme activity which is expressed as the amount of 
activity that converts one mole of substrate per second under 
given conditions. IU /L corresponds to 16.67 nkat/L (Cohn et 
ai, 1973). 
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2.1.2 Enzyme assay 
Enzymes are measured by their catalytic properties. 
Results of the measurement are in principle method-
dependent. Therefore these measurements have to be carried 
out under well-defmed conditions if the results are to be 
comparable. The analytical factors affecting enzyme 
measurement are shown as follows: 
Substrate concentration: When the amount of enzyme is 
limited and the reaction rate is directly proportional to 
substrate concentration, while the binding sites are saturated 
the rate is constant. In clinical chemistry, normally five to ten 
times the required amount of substrate is provided so that 
enzyme activity is the only rate-limiting factor in the assay. 
Enzyme concentration: Within an appropriate range of 
substrate concentrations the catalyzed reaction is directly 
proportional to the enzyme activity. 
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Temperature: Increase in temperature usually increases the 
rate of enzyme reaction until the temperature is high enough 
to cause deterioration of enzyme activity. 
pH: Being proteins, enzymes are normally ionized in body 
fluids. Extreme pH levels may denature an enzyme by change 
in the charge on the amino acid residues in the enzyme. In 
the laboratory, the pH for a reaction is carefully controlled by 
appropriate buffer solution. 
Cofactors: These enhance chemical reaction rate: one of 
mechanisms being through alteration of the spatial 
configuration of the enzyme for the proper substrate. 
Inhibitor: These are substances that inhibit enzyme activity. 
Some of them compete with the substrate for the active site, 
while others bind to the active site of the enzyme. Others 
bind only to the enzyme-substrate complex to form 'stable' 
complex. 
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2.2 Clinical aspects of enzymology 
Before 1940 the only enzymes whose activities were 
measured for clinical diagnosis were the hydrolysis enzymes: 
lipase, amylase, pho sphate se , trypsin and pepsin. At the 
present time, more than 20 different enzymes are assayed 
routinely in most clinical laboratories. The reason for the 
change in emphasis is largely due to increased understanding 
and awareness of the molecular details of metabolism and to 
the development of rapid and reliable methods of enzyme 
assay. The discovery in the 1950s of the association between 
the activities of serum aminotransferases and dehydrogenase 
with heart and liver disease gave the impetus to search for 
other enzymes present in serum that could be of diagnostic 
value. 
For measurement of an enzyme activity to be useful in 
clinical diagnosis the following conditions should be met. The 
enzyme should be present in blood, urine, or some readily 
available tissue fluid and be easy to assay. The differences in 
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the ranges of enzyme activities obtained from normal and 
diseased subjects should be diagnostically significant and 
there should be a good correlation between the level of enzyme 
activity and the pathological state. 
The rationale of enzyme measurement for diagnosis is 
that if a tissue is broken down or if it is producing an 
abnormally high amount of intracellular enzyme, which is 
then released, there is an elevation of enzyme activity in the 
serum. For several enzymes there is a very high concentration 
gradient across the cell membrane to the extracellular fluid 
and a small amount of tissue damage may affect considerably 
the serum concentration of certain enzymes (Nicholas et al 
1989). 
Plasma is the fluid in which most measurements of 
enzyme activities are made. The measured level of activity of 
enzyme in blood is the result of a balance between the rate 
entering in blood and the rate of enzyme is being inactivated 
and removed. The mechanisms leading to extracellular release 
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of enzymes are still poorly understood. Examples of 
pathological conditions where enzymes are released include 
ischaemia, shock, toxic and inflammatory conditions, 
mechanical and physical destruction of tissue. These enzyme 
changes may be related to the following processes (Kristensen 
et al 1996): 
(1) Any process that impairs energy production, either by 
depriving the cell of oxidizable substrates or by reducing 
the efficiency of energy production e.g. by restricting effect 
of oxygen transfer across the cell membrane. 
(2) Direct cell membrane damage. 
(3) Release of membrane-bound enzymes accompanied by 
increased rate of synthesis and breakdown of membrane 
components. 
(4) Release of mitochondrial enzymes may be related to the 
absence of adenine diphosphate (ADP). 
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The following paragraphs will introduce the characteristics of 
the enzymes studied in this thesis. 
2.2.1 Alanine aminotransferase (ALT, EC 2.6.1.2*) 
Tissue source: Alanine aminotransferase IS a cytosolic 
enzyme. It is found in a wide variety of organs, such as liver, 
kidney, heart, skeletal muscle and pancreas (HDrder et al, 
1983). Its activity is highest in the liver and lowest in the 
erythrocyte, so slight hemolysis does not affect the 
determination of its activity in plasma. It is considered to be 
the most liver-specific enzyme of all the transaminase 
enzymes in blood circulation (Wise et al, 1985). 
Physiology change and catalyzed" reaction: Siest and 
colleagues have shown that AL T activity in serum is slightly 
different between children and young adults. Higher values 
have also been found in 30 to 40 years old men and 50 to 60 
years old women. They also demonstrated that AL T enzyme 
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activity in males IS dependent of weight. (Siest et al, 1975). 
ALT catalyzes the transfer of an amino group from alanine to 
a-ketoglutarate with the formation of glutamate and pyruvate. 
The optimum pH is 7.3 to 7.8 (Wise et al, 1985). The reaction 
is shown by the following equation: 
Alanine + a-Ketoglutarate • ALT ~ Pyruvate + Glutamate 
Diagnostic significance: Clinical application of AL T assays 
are confmed mainly to the evaluation of hepatic disorders. 
Higher elevations are found in hepatocellular disorders than 
in extra- or intrahepatic obstructive disorders. In acute 
inflammatory conditions of the liver, AL T elevations will 
frequently be higher than those of AST and will tend to remain 
elevated longer, owing in part to the longer half-life of AL T. 
Cardiac tissue contains a small amount of AL T activity, but 
the serum level usually remains normal in acute myocardial 
infarction unless subsequent liver damage has occurred. 
A four digital number system for classification of each enzyme character by Enzyme Commission (EC). The first three 
-numbers define major class, subclass and sub-sub class respectively. The last number means enzyme number within sub-
subclass (MOSS, 1983). 
21 
2.2.2 Aspartate aminotransferase (AST, EC 2.6.1.1) 
Tissue source: The activity is high in the liver, heart and 
skeletal muscle with smaller amounts in the kidney, the 
pancreas and erythrocytes. Therefore slight hemolysis should 
not affect the activity in the plasma. The enzyme occurs in 2 
principal forms, one originates in cytosol (s-AspAT), with a 
molecular weight of about 93000 daltons and the other is in 
mitochondria (m-AspAT), with a molecular weight of 91000 
daltons. Normally the cytosol form predominates in the serum 
(Rej et al, 1983). 
Physiological change and catalyzed reaction: In children, 
AST activity is lower than in young adults. It has been 
demonstrated that men have higher activity than women but 
after the menopause such differences disappear (Cherian et 
al, 1978). AST catalyses transfer of amino groups between a-
keto acids. This transamination reaction is important ID 
intermediary metabolism because of its function in the 
synthesis and degradation of amino acids. The optimum pH is 
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between 7.3 and 7.8 (Wise et al, 1985). The reaction can be 
outlined by the following equation: 
Aspartate + a-Ketoglutarate .. AST ~Oxaloacetate + Glutamate 
Diagnostic significance: The clinical use of AST is confmed 
mainly to the evaluation of myocardial infarction, 
hepatocellular disorders and skeletal muscle damage. In acute 
myocardial infarction, AST levels begin to rise within 6 to 8 
hours, peak at 24 hours, and generally return to normal 
within 5 days. AST elevations are also frequently seen 
following pulmonary embolism. Following congestive heart 
failure, AST levels may also be increased, probably reflecting 
liver involvement due to inadequate blood supply to that 
organ (Wise et al, 1985). AST levels are highest in acute 
hepatocellular disorders. In viral hepatitis, levels may reach 
level may reach 100 times the upper limit of normal (ULN). In 
chronic liver disease e.g. cirrhosis, only moderate levels, 
approximately four times ULN are detected. Consistently 
elevated aminotransferase (AST, AL T) levels m these 
23 
conditions . are indicators of active disease. Skeletal muscle 
disorders, such as the muscular dystrophy and inflammatory 
conditions also cause increases in AST levels (Nemesanszky, 
1996). 
2.2.3 Gamma glutamyltransferase (GGT, EC 2.3.2.2) 
Tissue source: Gamma glutamyltransferase IS a cell 
membrane-associated enzyme, which functions to transport 
amino acids into the cell from the glomerular filtrate and from 
the intestinal lumen (Sherwin, 1996). Glutamyltransferase 
can be found in many organs such as kidney, pancreas, liver, 
small intestine and prostate etc. (Shaw et al, 1983), although 
its highest activity is in the renal tubules, where it is 12 
times higher than in the pancreas and 25 times higher than 
in the liver. Serum GGT is also elevated as a result of liver 
disease. 
Physiology change and catalyzed reaction: 
Glutamyltransferase is found to be higher in men than in 
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women because of small amounts of GGT released from the 
prostate. It is also higher in overweight persons and slightly 
elevated in women who are taking ovulation inhibitors 
(Schiele et al, 1977). It is involved in the transfer of the y-
glutamyl residue from y-glutamyl peptides to amino acid, H20 
and other small peptides. The catalyzed reaction of GGT is 
shown in the following equation: 
L-y-glutamyl-3-carboxy-4-nitranilide + glycylglycine 
GGT 1 
y-glutamyl- glycylglycine + 5-amino-2-nitrobenzoate 
Diagnostic significance: In the liver, GGT is located in the 
canaliculi of the hepatic cells and particularly in the epithelial 
cells lining the biliary ductules. Because of these locations, 
GGT is elevated in virtually all hepatobiliary disorders, making 
it one of the most sensitive of enzyme assays in these 
conditions. Higher elevations are generally observed in biliary 
tract obstruction (Wise et al, 1985). 
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Within the hepatic parenchyma, GGT exists to a large 
extent in the smooth endoplasmic reticulum, and is therefore 
subject to hepatic microsomal induction. Thus, GGT levels 
will be increased in patients receiving enzyme-inducing drugs 
such as warfarin, phenobarbital and phenytoin (Mass et al, 
1982). 
Because of the effects of alcohol on GGT activity, GGT 
assays are considered sensitive indicators of alcoholism,· 
particularly occult alcoholism, when other indications are 
lacking. Generally, there are enzyme elevations in alcoholics 
and heavy drinkers ranging from two to three times the ULN, 
although higher levels have been observed. In contrast, 
studies of the effects of normal social drinking reveal no 
significant elevations (Rosalki et aI, 1975). GGT assays are 
also useful in monitoring the effects of abstention from 
alcohol. Levels usually return to normal within two to three 
weeks after cessation but can rise agrun if alcohol 
consumption is resumed. 
26 
Glutamyltransferase levels are elevated ill other 
conditions such as acute pancreatitis, diabetes m ellitus, and 
myocardial infarction. The source of elevation in pancreatitis 
and diabetes is probably the pancreas, but the source of 
GGT in myocardial infarction is unknown (Wise et al, 1985). 
2.2.4 Creatine kinase (creatine phosphokinase CK, CPK, EC 
2.7.3.2) 
Tissue source: Creatine kinase occurs in order of decreasing 
catalytic concentration in skeletal muscle, myocardium, brain, 
gastrointestinal tract, thyroid, kidney, and liver in humans. 
Creatine kinase activity in erythrocytes is low (Gerhardt, 
1983). It has a molecular weight of 85000 dalton (Chapman et 
al, 1996). Creatine kinase occurs as a dimer consisting of two 
subunits M (muscle) and 8 (brain), the combination of MM 
(muscle type), MB (hybrid) and BB (brain type). In the sera of 
healthy persons, the major isoenzyme is the MM form, 
representing approximately 940/0 to 1000/0. Values for the MB 
isoenzyme range from undetectable to trace (less than 6%). It 
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also appears that CK-BB is present in small quantities in the 
sera of healthy persons. Skeletal muscle contains almost 
entirely CK-MM with a small amount of CK-MB. CK-BB is 
highest in brain, prostate, gut, lung, bladder, uterus, placenta 
and thyroid; CK-MM predominates in skeletal and cardiac 
muscle; cardiac and skeletal muscle also contains CK-MB 
(Henderson, 1996). 
Physiology change and catalyzed reaction: In the healthy 
state, serum CK is influenced by many factors, including age, 
sex, race, lean body mass and physical activity. Activities are 
higher for men than for women. Creatine kinase activity in the 
serum of women is not influenced by the menstrual cycle or 
by ovulation inhibitors. In physical activity, CK activities are 
elevated depending on the duration of exercise (Karamizrak et 
al, 1994). A rise ill activity is also observed after 
intramuscular injection of a number of drugs (Wise et al, 
1985). 
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Creatine kinase is associated with ATP regeneration in 
muscular contractions. Contractions require a supply of 
energy, usually provided by the creatine phosphate utilization 
with the energetic phosphates of adenosine triphosphate 
(ATP). For the contraction to take place, the ATP level in the 
muscular cell must not be high, hence the need for a 
mechanism capable of storing this basic source of energy 
while preventing it from inhibiting the actual contraction. The 
reversible reaction catalyzed by creatine kinase is shown by 
the following equation: 
Creatine + ATP .. CK ~ Creatine phosphate + ADP 
Diagnostic significance: Because of the higher 
concentrations of CK in muscle tissue, elevated CK levels in 
serum are frequently noted in disorders of cardiac and 
skeletal muscle. CK levels are considered the most sensitive 
indicator in acute myocardial infarction and muscular 
dystrophy, particularly Duchenne muscular dystrophy. In 
fact, the most striking elevations of CK occur in Duchenne 
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muscular dystrophy, with values reaching 50 to 100 times the 
upper limit of normal. Although total CK levels are sensitive 
indicators of these disorders, they are not entirely specific in 
as much as CK elevation is found in other abnormalities of 
cardiac and skeletal muscle (Rosalki, 1996). 
Elevated CK levels also are seen occasionally in central 
nervous system disorders such as cerebral vascular accident, 
seizures, nerve degeneration and central nervous system 
shock. Damage to the blood-brain barrier must occur to allow 
enzyme release into the peripheral circulation. 
Other pathophysiologic conditions in which elevated CK 
levels occur are hypothyroidism, malignant hyperpyrexia and 
Reye's syndrome. 
Because enzyme elevation is found ill numerous 
disorders, the separation of total CK into its various 
isoenzyme fractions is considered a more specific indicator of 
various disorders than are total levels. In the case of CK-BB, 
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it passes into the circulation when extensive damage to the 
blood-brain barrier has occurred. Cardiac tissue contains 
significant quantities of CK-MB, approximately 20% of all CK-
MB. Whereas CK-MB is found in small quantities in other 
tissues, myocardium is essentially the only tissue from which 
CK-MB enters the serum in significant quantities. A rise 
greater than 6% of the total CK is considered the most 
specific indicator of myocardial damage, particularly in acute 
myocardial infarction (Herderson, 1996). 
2.2.5 Lactate dehydrogenase (LDH, EC 1.1.1.27) 
Tissue source: Lactate dehydrogenase is a ubiquitous enzyme 
found in the cytoplasm of nearly in human cells. Lactate 
dehydrogenase has a molecular weight of 134000 daltons 
(Henderson et al, 1996). In human tissue extracts, the LDH 
activity decreases in the following order: Kidney > heart > 
skeletal muscle> pancreas> spleen> liver> lung> placenta. 
Lactate dehydrogenase activity IS also present ill 
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thrombocytes, leukocytes and erythrocytes. Hemolysis leads 
to a rise of activity in plasma (V assault, 1983) 
Physiology change and catalyzed reaction: The lowest 
serum LDH activities are to be found in 20 to 30 years old 
adults. Increased activity has been found in childhood and 
advanced age. In women, lactate dehydrogenase activity varies 
little with the menstrual cycle. It catalyzes the interconversion 
of lactic and pyruvic acids with simultaneous reduction of 
NAD+. The reaction is outlined in the following equation: 
Lactate + NAD+ .. LDH ~ Pyruvate + NADH + H+ 
The optimal reaction pH for the forward reaction is 8.3 to 8.9 
while for the reverse reaction it is 7.1 to 7.4. Because LDH is 
present in high activity in many organs, an increase is non-
specific (Wise et al, 1985). 
Diagnostic significance: Because of its widespread activity in 
numerous body tissues, LDH is elevated in a variety of 
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disorders . . Increased levels are found in cardiac, hepatic, 
skeletal muscle and renal disease, as well as in several 
hemaotologic and neoplastic disorders. The highest levels of 
LDH are seen ill pernICIOUS anemIa. Intramedullary 
destruction of erythroblasts causes elevations due to the high 
concentration of LDH in erythrocytes. Liver disorders such as 
viral hepatitis and cirrhosis show slight elevations of two to 
three times ULN. Acute myocardial infarct and pUlmonary 
infarct also show slight elevations of approximately the same 
degree. In acute myocardial infarction, LDH levels begin to 
rise within 12 to 24 hours reaching peak levels within 48 to 
72 hours. 
Because many conditions contribute to its increased 
activity, an elevated total LDH is nonspecific for any disease. 
But it assumes more clinical significance when separated into 
isoenzyme fractions. The enzyme can be separated into five 
major fractions. Each isoenzyme is composed of four 
polypeptide chains, two different polypeptide chains, 
designated H (heart) and M (muscle), combined in five 
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arrangements to yield the five maJor Isoenzyme fractions 
(LDHl, LDH2, LDH3, LDH4 and LDHs). In myocardial infarction, 
LDHl and LDH2 increase in serum within 24 to 48 hours after 
an infarct. In pUlmonary infarction LDH3 frequently becomes 
the predominant band. The LDH4 and LDHs isoenzymes are 
found primarily in liver and skeletal muscle tissue (Wise et al, 
1985). 
2.3 Changes enzymes in neonates 
It is well known that the activities of aspartate 
aminotransferase, alanine aminotransferase, and of y-
glutamyltranferase in blood are correlated to the hepatic 
function. The development of acute myocardial infarction 
results in changes in the activity of creatine kinase, aspartate 
aminotransferase, and lactate dehyrogenase in adults, and 
these are well understood. Recently some studies have 
reported on the serum enzyme activities in newborns. 
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2.3. 1 Aspartate aminotransferase (AST) & alanine 
aminotransferase (AL T) 
Aspartate aminotransferase activity in cord blood from 
the 20th to 26th weeks of gestational age is not different to that 
in the maternal serum (Forestier et al, 1987). Zanardo (1983) 
studied AL T and AST in newborns in relation to the 
gestational age; they found that both enzymes were significant 
higher in the newborns with a gestational age of < 32 weeks 
than those with a gestational age ~ 32 weeks. Blum and 
colleagues (1975) reported that at 10 days of age, term 
infants had higher AST and AL T levels than preterm and this 
can be interpreted as an immaturity of enzyme synthesis. 
Fetal distress, defmed as passage of meconIum and 
abnormal fetal heart tracings, was associated with a 
significant increase in AST activity in capillary blood (Parmar 
et al, 1980). In another study, by Beckett in 1989, ALT 
activities were significantly higher in infants who had a 
clinical diagnosis of birth asphyxia at 24 to 48 hours of age. In 
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a serial blood sampling study (Zanardo et al, 1985), 50 
asphyxiated neonates were recruited and separated into 
preterm and term groups. The results showed that in 
newborns with clinical symptoms of asphyxia, AST activity 
increased significantly during the first 72 hours of life and 
tended to normalize between the 5th and 10th day of life. The 
mean AST activity in full-term asphyxiated newborns was 
significantly higher than in premature asphyxiated newborns 
and tended towards adult values between the 20th and the 30th 
day of life. Similarly ALT was higher in full-term asphyxiated 
newborns than in control subjects, particularly · in the fIrst 
weeks of life. In full-term asphyxiated newborns the mean 
value of AL T was persistently higher than in premature 
asphyxiated newborns, all through to the 30th day of life. The 
lower levels of transaminase enzymatic activity during the 
first days of life in premature newborns with sustained 
perinatal asphyxia was attributed to higher resistance of the 
membranes to the hypoxia-ischemic injuries in premature 
newborns, and may be related to a lower enzymatic pool of 
cellular metabolism in relation to gestational age. Lackmann 
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and colleagues (1993) demonstrated that full-term 
asphyxiated newborns had significantly increased serum 
activities of AST up to 72 hours of life. A later study by the 
same author (1995) showed that full-term asphyxiated 
newborns with hypoxic-ischemic encephalopathy or 
periventricular-intraventricular hemorrhage showed 
significantly increased serum activities of AST within the first 
72 hours of life. 
2.3.2 Gamma-glutamyltranferase (GGT) 
Gamma glutamyltransferase activity in cord blood 
remains constant throughout gestation (Bakker et al, 1974; 
Moniz et al, 1984; and Hallak et al, 1994). Davidson (1974), 
Walker (1974), Moniz (1984) and Hallak (1994) have shown 
that the activities of GGT in cord blood were higher than in 
the adult. The higher value in cord blood may relate to hepatic 
immaturity (Garcia et al, 1987) or may be due to minor insults 
to the microsomal systems acquired during labor or in the 
antenatal period (Davidson et al, 1976). 
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In a study by Bartnicki and colleagues (1989), GGT 
levels were measured in umbilical arterial blood immediately 
after delivery. They found the levels to be normal «80 IU /L ) 
in 76% of the neonates born to mothers with normal 
placental function. In 63% of the mothers with placental 
insufficiency the GGT levels were found to be above 80 IU /L. 
Increased enzymes levels were also associated with decreased 
pH in the umbilical cord artery. These authors suggested that 
placental dysfunction caused chronic fetal hypoxia and this in 
turn induced fetal liver cell damage that resulted in increased 
GGT activity. 
In another study (Rivera et al, 1990), GGT activity was 
measured in the cord blood of 125 preterm and term neonates 
ranging from 26 to 42 weeks of gestation. The enzyme activity 
was higher in cord blood of infants from 33 to 37 weeks 
gestation than in those of earlier or later gestations. 
Furthermore, GGT activity in infants of greater than 37 weeks' 
gestation was significantly higher in male than in female 
infants. GGT in term infants with a history of perinatal events 
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suggestive of stress (meconium passage ill utero, fetal 
decelerations, tight nuchal cord or difficult delivery) was 
significantly higher than in term infants without such a 
perinatal history. No such association existed ill infants of 
less than 38 weeks' gestation. Infants of 33 to 37 weeks 
gestation delivered vaginally had significantly higher cord 
GGT activity than those delivered by cesarean section. This 
difference was not apparent in younger or older infants. 
According to these authors, preterm infants do not respond 
to perinatal events indicative of stress, possibly because the 
mechanism necessary to respond to the stress factor may not 
be developed. The difference between male and female infants 
may be related to the greater activity of GGT in seminal 
vesicles and seminal plasma as well as in testicular tissue. 
2.3.3 Lactate dehydrogenase (LDH) 
Irrespective of asphyxial insult , LDH activity was 
decreased up to the end of the fIrst week of life after a short 
increase immediately after birth, but it was significantly 
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higher in the asphyxial group when compared with control 
infants during the whole first week of life. The characteristic 
postpartum increase of LDH seems to be the result of a 
hypoxia-induced release from tissue during the perinatal 
period. No significant difference was found between male and 
female infants (Lackmann et al, 1993). 
In intrauterine death cases, LDH levels were 
significantly higher in the amniotic fluid than in normal 
pregnancies and there was a tendency for LDH to increase 
from the time of suspected fetal death to fluid sampling. The 
resulting high LDH activity may originate from the foetus 
undergoing gradual maceration with consequent liberation of 
cellular breakdown products into the amniotic fluid (Moe et al, 
1977). Another study has shown that perinatal asphyxia 
significantly elevated LDH in cerebrospinal fluid in infants and 
who die from hypoxic encephalopathy. The high levels in 
cerebrospinal fluid may be partly derived from increased 
permeability of the blood brain barrier or from neuronal origin 
(Hall et al, 1980). 
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2.3.4 Creatine kinase (CK, CPK) 
Creatine kinase is released during muscular trauma and 
myopathic disorders, as well as in myocardial infarction in 
adults. In neonates the total CK (Jouppila et al, 1978; 
Jedeikin et al 1982) and its isoenzymes (Jouppila et al, 1978; 
Cuestas, 1980; Jedeikin et al, 1982; and Primhak et al, 1985) 
rise dramatically after delivery and fall to normal after 2-3 
days, irrespective of asphyxial insult. The activities of total CK 
in normal infants' cord blood are higher when compared with 
adults. These increased enzyme levels in early life in infants 
may be due to the trauma of natural birth. In cord blood the 
predomiI~ant CK Isoenzyme IS muscle type (CK-MM) 
(Chemnitz et al, 1979; Niklinski et al, 1987; Amato et al, 
1992; and Fonseca et al, 1995). The brain type isoenzymes in 
cord blood have been widely reported (Chemnitz et al, 1979; 
Amato et al, 1992; and Fonseca et al, 1995), but some 
conflicting data had been reported regarding of the presence of 
hybrid type isoenzyme (CK-MB) in cord blood. Fonseca 
(1995) found CK-MB present in about 37 % to 430/0 of total 
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CK but Amato (1992) reported no CK-MB in cord blood. 
Although the main source of serum CK-BB in man is brain, 
this isoenzyme is also found in the gastrointestinal tract, 
lung, uterus, kidney (Wise et al, 1985) , placenta (Laboda et al, 
1977) and both umbilical arterial and venous vessel walls 
(Kumpel et al, 1983). Increasing activity of this enzyme in 
blood after birth must be due to release from tissues in the 
newborn infants and probably mainly the brain (Cuestas in 
1980). This was suggested by the fact that in infants with 
pulmonary edema, necrotizing enterocolitis and renal failure 
due to polycystic kidneys, CK-BB was not 'significantly 
different when compared to control patients. 
CK-BB activities were significantly higher in umbilical 
cord arterial blood (Ruth et al, 1989) and in neonatal blood 
samples at 4 hours of life (Fernandez et al' 1987) in those 
who died of severe hypoxic-ischaemic encephalopathy or 
developed neurological sequelae than in those who had no 
neurological abnormalities at follow-up. It appears that the 
presence of elevated serum CK-BB activity can be a sensitive 
42 
indicator of significant brain damage, but not of neurological 
damage in survivors. Walsh and colleagues ( 1982) have 
demonstrated that CK-BB was greater than 2.5 log-
transformed standard deviations above the mean of the 
control values in ten asphyxiated infants. When normal CK-
BB activity was used as a predictor of good neurologic 
outcome and elevated CK-BB as a predictor of subsequent 
neurologic abnormality, the outcome was predictable from the 
CK-BB in 17 of 22 cases (770/0) and in 11 of the 12 survivors 
(92%). Eight of the 12 surviving infants had neonatal 
seizures. They conclude the CK-BB measured in cord blood 
and at 6 to 12 hours of life predicts neurologic outcome after 
severe asphyxia. 
In serial sampling studies, Andronikou and colleagues 
(1995) found that neonates with evidence of intrauterine 
stress (convulsion, hypotonia, absence of sucking reflex) had 
an increase in their CK-BB at 6 hours of life in comparison 
with babies born without signs of stress. 
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In a very low birth weight premature study (gestational 
age below 32 weeks and birth weight below 1400 gram), Speer 
(1983) found that all 19 infants with fIrst sample value (12 
hours age of life) of CK-BB > 19U jL had PIVH (periventricular 
j intraventricular hemorrhage). There was a significantly 
higher mortality during the fIrst two weeks of life in the 
patients with PIVH with CK-BB > 19U jL (13 of 19) as 
compared with the patients with PIVH but CK-BB < 19UjL 
and the 15 patients without PIVH. They suggested this 
enzyme is a useful test to predict both the occurrence of PIVH 
and short-term mortality in a very low birth weight 
population. 
In birth asphyxia, total CK and its isoenzymes were 
significantly higher than in controls (Warburton et al, 1981; 
Primhak et al, 1985; and Fonseca et al, 1995). However 
Niklinski (1987) in his study found no significant elevation in 
levels of total CK, CK-MM and CK-MB in infants born of 
mothers with either normal or impaired placental function nor 
a difference in normal or asphyxiated newborns (defined as 
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Apgar Score at 5 minutes below 7), but a significant rise of 
CK-BB was found in cord sera of newborns delivered from 
pregnancies with placental dysfunction as well as in cases of 
asphyxiated infants. The possible explanation is that skeletal 
muscle is scarcely vulnerable to an hypoxic state and 
elevation of CK-BB activity could be considered as a possible 
indicator of cerebral injury. 
In other studies, total CK (Warburton et al, 1981) was 
higher in blood samples collected at 4 hours of age and CK-
BB (Chemnitz et al, 1979; Amato et al 1986) was significantly 
higher in cord blood from those who had low Apgar Score at 
1 minutes of life. Chemnitz ( 1979) suggested that the 
increase of CK-BB may be a result of immaturity of the fetal 
blood-brain barrier, allowing an enzyme leak from the brain 
into blood serum. Warburton (1981) suggested that because 
CK correlated to both the 1 minute Apgar Score and 5 minute 
Apgar Score, CK-BB may not truly represent the degree of 
perinatal insult as the latter values may be influenced by the 
effects of resuscitation. 
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Changes in fetal CK and its isoenzymes in relation to 
abnormal fetal heart rate tracings have been described. For 
example, Woolley and colleagues (1983) reported that the 
percentage of CK-MB at 30 ± 6 hours in peripheral blood was 
significantly higher in neonates with abnormal fetal heart rate 
tracings (p<O.Ol) and this was suggested as an indicator of 
myocardial injury. Feldman (1985) found that infants with an 
ominous fetal heart rate had higher CK-88 levels in cord 
blood and poor outcome, but no differences were seen in CK-
MM or CK-MB. It was suggested that ominous fetal heart rate 
patterns are associated with fetal hypoxia significant enough 
to cause central nervous system injury. Another study 
(Hollander et al, 1987) has shown CK-MB and BB to be higher 
in fetal distress (diagnosed as abnormal fetal heart rate 
tracing alone) and significantly correlated with the degrees of 
base excess in cord blood but not with pH value. The author 
suggested that these isoenzymes changed only after prolonged 
hypercar bia. 
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A few studies have reported on changes in CK and its 
isoenzymes (CK-MM and CK-MB) in relation to delivery 
patterns ( Jedeikin et al, 1982; and Malamitsi-Puchner et al, 
1993). They have shown higher CK values in normal deliveries 
when compared to an elective cesarean section group. 
Jedeikin (1982), Malamitsi-Puchner (1993) and other 
researchers (Speer et al, 1983; and Liras et al, 1988) 
demonstrated no difference in CK-BB between normal 
deliveries and elective ceSarean section groups in cord or 
postpartum serum. Jedeikin (1982) suggested that this may 
be related to the biological half-life of this isoenzyme in blood 




Materials and Methods 
3.1 Study population 
Pregnant women admitted to the Labour Ward of the 
Prince of Wales Hospital, Shatin, Hong Kong during the period 
from October, 1995 to January, 1997 were assessed. During 
this period, at least two hundred and flily two cases would be 
recruited. The sample size required was based upon expected 
correlation coefficient of 0.3 with significance level a < 0.01 
and Power = (1- ~) of 0.9. The protocol wa"s approved by the 
Clinical Research Ethics Committee of the Chinese University 
of Hong Kong. Those who satisfied the following criteria were 
recruited after giving informed consent: 
1. Singleton pregnancy 
2. Gestational age between 37 and 42 weeks 
- according the fIrst day of the last menstrual period (LMP) 
and early stage pregnancy by ultrasound assessment 
3. Maternal viral hepatitis negative 
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4. Exclusion of maternal complications (e.g. pre-eclampsia) 
5. Exclusion of congenital malformations of the baby, 
diagnosed following 
- ultrasound screening antepartum or at delivery 
- postnatal follow-up 
3.2 Sample collection and Storage 
Cord blood samples were taken after vaginal delivery of 
the baby but before placental expulsion. For cesarean sections 
blood samples were taken at the time the placenta was 
removed. In each case, two separate samples were taken: one 
for blood gas assay, the other for enzyme assay. 
3.2.1 Cord blood for blood gas assay. 
Syringe preparation: all plastic syringes were heparinized by 
adding liquid heparin (1: 1000 units), moving the plunger up 
and down and then expelling any residual heparin. A 23G x I" 
needle connected to a 2.5 ml syringe was used for collecting 
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blood from the cord artery, and a 21 G x 11 / 2 needle connected 
to a 5 ml syringe was used for collecting blood from the cord 
vein. This arrangement was devised to prevent confusion after 
blood sampling. 
Cord blood sampling: A segment of cord was clamped 
immediately after delivery and blood was drawn within 5 
minutes of birth. Blood was taken fIrst from the artery and 
then from the vein. Care was taken to avoid drawing air into 
the syringe: immediately after drawing the blood sample all air 
was expelled from the syringe and it was capped securely. 
Samples were then placed through the automatic analyzer 
within 5 minutes. 
Cord blood gas assay: a CIBA -Corning 278 Blood Gas 
Analyzer was used throughout the study. The analyzer was 
serviced daily by technicians from the Department of 
Chemical Pathology. The result of blood gas parameters were 
printed out and the data entered into a SPSS file. 
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3.2.2 Cord blood for enzymes assay. 
Cord blood sampling: 10 ml of venous cord blood was taken 
with a heparinized syringe at the time of cord blood sampling 
for blood gas analysis. 
Sample storage: All blood samples were centrifuged at 3000 
rpm for 10 minutes and the plasma separated as soon as 
possible. If this was not possible the blood sample was placed. 
at 4 oC for a maximum 1 hour. Blood samples which exhibited 
visible hemolysis were discarded. All speCImens of plasma 
were stored at -78 oC until enzyme assay. 
3.3 Determination of cardiac and hepatic enzymes in 
plasma 
Plasma cardiac enzymes (CK, LDH) and hepatic enzymes 
(AST, AL T, GGT) were measured by the Department of 
Chemical Pathology, Prince of Wales Hospital, Shatin, Hong 
Kong. Activity of enzymes was measured automatically by 
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(Roche) Cobas Bio System (F. Hoffmann- La Roche and Co. 
Limited Basle, Switzerland 1983) which is a single unit self-
contained centrifugal analyzer and utilizes a unIque 
horizontal light path. The principle utilizes enzyme kinetic 
reaction rate; absorbance points were taken after the reagent 
was mixed with plasma. All absorbance points were read 
according to the programmed time of fIrst reading and time 
intervals, then Cobas Bio performed a linear search of each 
cuvette individually to fmd the linear portion of the data. A 
linear regression is then carried out, calculating absorbance 
difference per minute ("'A/min.) from the slope of the 
regressIon line and activity by taking this ("'A/min.) * 
calculation factor. All samples were measured automatically 
after the programs were set, samples filling in sample cup, 
working reagent was prepared and placed in reagent tray. All 
the results of activity of enzyme in plasma are presented in 
U/L. 
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3.3. 1 Coefficient of variation (CV). 
Quality control of CK, LDH, AST, AL T, GGT was used to 
establish the coefficient of variance for within batch and 
between batches in each enzyme. The result of CV of within 
batch and between batch is summarized in the following 
tables 3.3-1 to 3.3-2. The CV of between batch and within 
batch are below 10% and 5% respectively. The frrst and 
last samples in each run were selected for quality control 
during the study blood samples' measurement to make sure 
that run measurement assay was precise. 
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Table 3.3-1 Coefficient of Variance Between Run (UjL) 
ALT ALT AST AST CK CK · GGT GGT LDH LDH 
n ab n ab n ab n ab n ab 
32.03 155.24 29.90 116.10 113.48 356.42 18.8169.62 184.17 542.99 
37.44 159.70 32.56 114.75 114.04 365.98 17.85 70.95 198.03 558.67 
32.35 145.46 36.61 121.51 121.02 369.53 17.54 71.62 196.00 568.84 
............................................................ ............................................................................................................. .................................................................................... ........................................................................................................................................ 
29.43 159.76 32.37 133.22 114.59 327.52 18.83 74.04 204.59 605.09 
......................................................................................................................................................................... ......... .................................................................................................................................................................................................................... 
28 .05 148.37 40.04 117.99 122.45 350.66 21.84 70.05 225.66 567.63 
.................................................................................................................................................................................................................. ................................................................................................................................................................................... 
36.15 160.05 41.35 117.88 109.72 352.43 20.27 73.75 197.20 593.09 
37.92 160.86 27.91 115.23 118.44 347.26 18.10 72.83 218.98 576.92 
28.29 157.68 35.10 114.69 110.17 343.75 20.40 71.84 211.76 590.05 
.............................. .............................. ...... .. .............................. ....................................................................... ................................................................................................................................................................................................................... .......... 
33.85 149.21 35.79 130.36 121.84 353.89 18.94 70.80 198.26 557.46 
32.37 153.93 34.17 113.32 115.14 322.29 16.89 71.81 202.09 576.15 
.............................. ............................................................................................................................................................................................................................... ........................................................................................................................................ 
28.91 148.47 31.81 119.64 113.84 331.93 18.72 71.84 203.09 592.61 
34.75 149.35 34.07 112.54 103.64 331.64 18.39 74.19 214.82 607.12 
32.36 154.00 33.69 114.11 109.08 344.55 20.06 73.84 222.27 494.19 
37.95 151.18 33.38 112.96 105.44 354.57 20.53 72.92 198.81 558.22 
............ ............................................................................................................................................................................................................................................................................................................................................ ............................................... 
33.29 159.91 33.72 125.41 116.43 358.06 18.69 73.02 211.16 586.21 . 
.............................. ....................................................................................................... ............................. ................................................ ........................................................................................................ .. ....................................... .................................. . 
30.10 161.39 31.28 123.79 107.64 364.00 19.44 75.10 217.49 560.21 
31.58 153.80 31.93 122.18 117.13 365.87 18.35 73.23 212.97 595.34 
.......................................................................................................................................................................................................... ........................................................................................................................................................................................... 
26.67 147.67 36.01 114.00 369.82 17.53 74.47 216.65 610.25 
31.38 148.40 33.91 118.34 17.94 73 .13 212.73 573.18 
35.02 144.28 35.41 122.19 18.49 240.39 
.................................................................. .. .. ................................................................. ................................................. ............... ......................................................... ................................................................................................ ....................................... 
33.07 152.97 36.98 113.41 20.42 224.48 
mean 32.66 153.41 34.19 119.16 114.38 350.57 18.95 72.58 210.08 574.43 
............................................. .................................................... .................................................................................................................. .. ................................................................................................................................................................................. 
SD 3.05 5.48 3.10 6.16 5.39 14.62 1.24 1.53 12.90 27.19 
............................................................................................................................................................. ....................... ............... _ .............. ................................................................................................................................................ ............................... .. .. 
cy 9.35 3.57 9.05 5.17 4.71 4.17 6.52 2.11 6.14 4.73 
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Table 3.3-2 Coefficient of Variance Within Run (U IL) 
ALT ALT AST AST CK CK GGT GGT LDH LDH 
ab n ab n ab n ab n ab 
36.02 147.17 40.41 147.10 117.84 35l.86 19.94 75.82 226.55 574.58 
36.91 153.54 39.13 152.81 126.33 383.70 20.48 76.36 227.75 580.17 
39.26 151.23 39.33 150.66 119.12 364.87 20.46 76.26 221.81 579.94 
38.02 151.11 40.03 150.99 123.32 371.89 20.33 75 .60 228.02 591.51 
39.24 150.17 38.86 150.56 113.96 377.10 20.57 76.48 223 .06 580.86 
................................................................. ................................................................................................................. ...................................... ........................................................................................................................................................................... 
37.05 148.83 39.22 148.44 123.82 380.80 20.17 77.39 222.37 573.10 
39.10 149.54 41.21 148.78 120.46 383.61 20.37 76.96 218.03 587.82 
37.58 147.23 41.90 148.40 127.99 386.86 20.82 75.99 220.15 577.03 
37.09 148.47 40.75 149.49 118.47 377.44 20.56 78.41 216.89 590.25 
38.02 150.77 38.92 146.80 114.01 387.67 20.76 74.33 21l.82 581.19 
37.29 153.48 41.19 150.99 116.65 387.94 20.88 75.63 221.31 592.27 
36.38 152.97 40.74 151.98 116.71 375.29 20.87 74.74 219.80 585.08 
38.42 153.86 41.93 149.46 112.37 362.78 20.93 75.18 218.18 593.03 
37.14 151.01 41.32 149.82 115.67 370.40 21.56 75.31 224.47 600.94 
........................................... ... .............................................................................................................................................. ....................................................... .... ........................................... ............................................................................................... 
37.71 150.40 42.11 153.84 114.34 368.02 21.28 75.55 222.89 591.56 · 
mean 37.68 150.65 40.47 150.01 118.74 375.35 20.67 76.00 221.54 585.29 
........................................................................................................ .................................. ......................................................................................................................................................................................................................................................... 
SD l.00 2.17 1.15 1.98 4.76 10.45 0.42 1.04 4.34 7.95 
................................ ............................... ....................................... .................................. ....................................... .......................................................................... .............................. . .......................................................................... . 
CV 2.65 1.44 2.85 1.32 4.01 2.78 2.02 1.37 1.96 1.36 
3.3.2 The measurement of alanine aminotransferase (ALT 
EC 2.6.1.2) activity in plasma 
The assay of AL T in plasma was performed according to 
the recommendation of the International Federation of 
Clinical Chemistry (IFCC). The principles of this procedure 
are based on AL T reversibly transferring the amino group 
from alanine to 2-oxoglutarate, thereby forming pyruvate and 
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glutamate. The rate of formation of pyruvate was determined 
by coupling the AL T reaction with that of LDH , which 
converts the pyruvate to lactate. The decrease in absorbance 
at 340 hm was measured as NADH was oxidized to 
nicotinamide adenine dinucleotide (NAD+) which was directly 
related to ALT activity. The reaction can be outlined in the 
following equation: 
L-alanine +' 2-oxoglutarate .. ALT ~ L-glutamate + pyruvate 
Pyruvate + NADH + H+.. LDH ~ L-lactate + NAD+ 
Settings for the program of the Cobas Bio system were as 
follows: calculation factor 9921 U /1, temperature measuring 
at 37 oC, measuring wavelength at 340 nm, sample volume 4 
J.!l, diluent volume 20 J.!l, reagent volume 225 J.!l, time of 
incubation was zero, time of first reading at 50 seconds after 
mixed reagent and sample, number of readings were 15 times 
and time interval at every 10 seconds. 
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Preparation of the reagent for Cobas Bio system: The 
reagent was in the form of a commercial Kit (Unimate 3), the 
composition of reagent 1 (RI) and reagent 2 (R2) can be shown 
as follows. The contents of RI was reconstituted with 6 ml of 
R2 and stirred. Mter blood samples were placed in the sample 
cups, then mixed with the reagent automatically by COMBAS 
BIO. The results of ALT was expressed in U JL. All experiments 
result were entered into a SPSS file. 
Kit contents (Roche-Unimate 3) 




Lactate dehydrogenase (LDH) 
Sodium azide 0.3 0/0 
Composition of reagent 2 (R2) Solvent 
2-0xoglutarate 
Sodium azide <0.1 0/0 
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3.3.3 The measurement of aspartate aminotransferase (AST 
EC 2.6.1.1) activity in plasma 
The assay of plasma AST was performed by the kinetic 
uv test according to the recommendations of the 
International Federation of Clinical Chemistry (IFCC). The 
principle of the mono-reagent method is outlined by the 
following equation: 
L-aspartate +2-oxoglutarate ..... __ A_ST_-+~ 
L-glutamate + oxaloacetate 
Oxaloacetate + NADH + H+ MDH L-malate + NAD+ 
..... ----+~ 
The rate of the NADH oxidation was directly related to the AST 
activity and was measured photometrically by recording the 
decrease in absorbance at 340 nm. 
Settings for the program of the Cobas Bio system were as 
follows: calculation factor 2480 U /1, temperature measuring 
at 37 oC, measuring wavelength 340 nm, sample volume 16 J..ll, 
diluent volume 30 ).ll, reagent volume 145 J..lI, time of 
incubation was zero, time of frrst reading at 50 seconds after 
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mixing reagent and sample, number of readings were 15 times 
and time interval at every 10 seconds. 
Preparation of the reagent for Cobas Bio system: The 
reagent was in the form of a commercial Kit (Unimate 3), the 
composition of reagent (RI) and reagent 2 (R2) can be shown 
as follows. The contents of RI was reconstituted with 6 ml of 
R2 and stirred. Mter blood samples were placed in the sample 
cups, then mixed with the reagent automatically by COMBAS · 
BIO. The results of AST was expressed in U /L. All 
experiments result were entered into a SPSS file. 
Kit contents (Roche-Unimate 3) 




Lactate dehydrogenase (LDH) 
Malate dehydrogenase (MOH) 
Sodium azide 0.3 0/0 
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Composition of reagent 2 (R2) Solvent 
2-0xoglutarate 
Sodium azide <0.1 0/0 
3.3.4 The measurement of y-glutamyltransferase (GGT EC 
2.3.2.2) in cord plasma. 
Glutamyltransferase is an enzyme involved in the 
transfer of the y-glutamyl residue from y-glutamyl peptides to 
amino acids, H20, and other small peptides. The assay of 
GGT in plasma was performed by the kinetic colorimetric test 
using L-y-glutamyl-3-carboxy-4-nitranilide (Roche Unimate 3) 
as a substrate. The principle is according the following 
reaction: 
L-y-glutamyl-3-carboxy-4-nitranilide + glycylglycine 
GGT 1 
L-y-glutamyl- glycylglycine + 5-amino-2-nitrobenzoate 
The rate of formation of 5-amino-2-nitrobenzoate was directly 
related to the GGT activity and was measured by recording 
the increase in absorbance at 405 nm. 
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Settings for the program of the (ROCHE) Cobas Bio system 
were as follows: calculation factor 1754 U /1, temperature 
measuring at 37 oC, measuring wavelength 405 nm, sample 
volume 15 J.lI, diluent volume 25 J.lI, reagent volume 125 J.lI, 
time of incubation was zero, time of fIrst reading at 60 
seconds after mixing reagent and sample, numbers of 
readings were 15 times and time interval at every 10 seconds. 
Preparation of the reagent for Cobas Bio system: The 
reagent was in the form of a commercial Kit (Unimate 3), the 
composition of reagent 1 (RI) can be shown as follows. The 
contents of RI was reconstituted with 6 ml of distilled water 
and stirred. Mter blood samples were placed in the sample 
cups, then mixed with the reagent automatically by COMBAS 
BIO. The results of GGT was expressed in U/L. All 
experiments result were entered into a SPSS file. 
Kit contents (Roche-Unimate 3) 





3.3.5 The measurement of creatine kinase (CK EC 2.7.3.2) 
activity in cord plasma 
The assay of creatine kinase in plasma was performed 
by the kinetic ultra-violet (UV) test according to the 
recommendations of the' Societe Fran<;aise de Biologie · 
Clinique (SFBC). The principle is CK activated by N-
acetylcysteine (NAC) and determined by the following reaction 
sequence: 
Creatine phosphate + ADP .... __ C_K_----.~ Creatine + ATP 
ATP +D-glucose .... _----o:;.;:o.H.:....:...K*_-+~ ADP + D-Glucose-6-P 
D-Glucose-6-P + NADP+ • G6P-DHt 
D-gluconate-6-p + NADPH + H+ 
* Hexokinase 
t Glucose-6-phosphate dehyrogenase 
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The rate of formation of NADPH was directly related to the CK 
activity and was measured photometrically in the increased 
absorbance at 340 nm. 
Settings for the program of [ROCHEl Cobas Bio system as 
follows: calculation factor 6614 Ujl, temperature measuring 
at 37 oC, measuring wavelength 340 nm, sample volume 6 ].11, 
diluent volume 30 }.ll, reagent volume 145 ].11, time of 
incubation was zero, time of fIrst reading at 50 second after 
mixed reagent and sample, number of readings were 15 times 
and time interval is every 10 second. 
Preparation of the reagent for Cobas Bio system: The 
reagent was in the form of a commercial Kit (Unimate 3), the 
composition of reagent 1 (RI) and reagent 2 (R2) can be shown 
as follows. The contents of RI was reconstituted with 6 ml of 
R2 and stirred. Mter blood samples were placed in the sample 
cups, then mixed with the reagent automatically by COMBAS 
BIO. The results of CK was expressed in U/L. All experiments 
result were entered into a SPSS file. 
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Kit contents (Roche-Unimate 3) 
Composition of reagent 1 (R 1) 
Creatine phosphate 
D-Glucose 
N -Acetylcysteine (NAC) 
Diadenosine pentaphosphate 
Adenosine monophosphate (AMP) 
EDTA 
NADP 
Adenosine diphosphate (ADP) 
Hexokinase (HK) 
Glucose-6-phosphate dehydrogenase (G6PD-DH) 
Reagent 2 (R2) Buffer 
Imidazole buffer pH 6.7 
Sodium azide<O.l 0/0 
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3.3.6 The measurement of lactate dehydrogenase (LDH EC 
1.1.1.27) activity in plasma. 
Plasma LDH was measured usmg kinetic UV test 
according to the recommendations of the SFBC. Its principle 
is outlined by the following equation: 
Pyruvate + NADH L-Iactate + NAD+ 
.... 4-----+. 
LDH 
The rate of the NADH oxidation was directly related to the 
LDH activity. It was determined by recording the decrease in 
absorbance at 340 nm. 
Settings for the program of the COMBAS BIO system: 
calculation factor 9921 U /1, temperature measuring at 37 oC, 
measuring wavelength 340 nm, sample volume 4 J.!l, diluent 
volume 20 J.!l, reagent volume 225 J.!l, time of incubation was 
zero, time of fIrst reading at 50 seconds after mixing reagent 
and sample, number of readings were 15 times and time 
interval at every 10 seconds. 
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Preparation of the reagent for Cobas Bio system: The 
reagent was in the form of a commercial Kit (Unimate 3), the 
composition of RI and R2 can be shown as follows. The 
contents of reagent 1 (RI) was reconstituted with 6 ml of 
reagent 2 (R2) and stirred. Mter blood samples were placed in 
the sample cups, then mixed with the reagent automatically 
by COMBAS BIO. The results of LDH was expressed in U fL. 
Ail experiments result were entered into a SPSS file. 
Kit contents (Roche-Unimate 3) 
Composition reagent 1 (RI) 
NADH 
Reagent 2 (R2) Buffer 
Tris buffer, pH 7.2 
Pyruvate 
Sodium chloride 
Sodium azide <0.1 0/0 
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3.4 Data handling and statistical analysis 
The raw data from experiments were entered into a 
personal computer. Since the distribution of enzyme activities 
in the neonate were shown to be significantly skewed, non-
parametric statistics were used to analyze the results. The 
Spearman's rank correlation coefficient was used to evaluate 
the correlation between two variables. Statistics were carried 
out using the software package - Statistical Package for Social · 
Sciences (SPSS Inc., ver 6.0, Chicago). A p-value of less than 
0.05 was considered significant in statistical calculation. 
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4.1 Study population 
Chapter Four 
Results 
A total of three hundred and twelve cases were recruited 
between October, 1995 and January, 1996 at the Prince of 
Wales Hospital, Shatin, Hong Kong. Cord vessels were 
considered incorrectly sampled if the value of pH or p02 in 
arterial blood was higher than in venous blood or the value of 
pC02 in arterial blood was lower than in venous blood. Those 
results were regarded as physiologically inconsistent. Mter 
excluding these cases, two hundred and eighty nine cases 
were available for statistical analysis. The characteristics of 
the study population were as follows: 
1. Maternal Characteristics: The mean of maternal age was 
29.7 years with a standard deviation (SD) of 5.3, the 
maximum was 43 years old and the minimum was 15 years 
old. Primiparas accounted for 47.40/0 of the population, with 
only 0.6% having parity of 4 or moreo 
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2. Labour: Mode of delivery was categorized into four groups. 
They were: normal spontaneous vaginal delivery group (ND), 
vacuum extraction group (V jE), emergency cesarean group 
(em CjS) and elective cesarean group (el CjS). The percentage 
for each group was 56.7% (164 cases), 20.70/0 (60 cases), 9.3% 
(27 cases) and 13.1 % (38 cases) respectively. The mean 
duration of first stage of labor (1st Stg) was 6.4 hours and the 
mean duration of second stage of labor (2nd Stg) was 36.6 
minutes. The presence of induced labor were noted in 26 · 
cases (10.3% ). 
3. Neonatal condition: The mean gestational age (GA) was 
277.7 days with a SD of 8.3 days. The presence of meconium 
stained liquor (MSL) was noted in 82 cases (28.4 %) which 
included thin or thick meconium stained liquor, or fresh 
meconium stained liquor. Nuchal cords (eRN) were noted in 
41 cases (14.2%) , including tight or loose cord round the 
neck. The range of arterial cord blood pH was from 7.03 to 
7.38 and mean value was 7.24. The range of base excess was 
from -13.3 to 1.4 mmol/L and the mean value was -5.28 
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mmol/L. In the study 159 (55%) babies were male and 130 
(45%) female. Their mean birth weight was 3350g and the 
standard deviation was 400g, range was from 2.05 to 4.8 Kg. 
One minute Apgar scores (1' Apg) were less than 7 in 16 cases 
(5.4%). In contrast, only 1 case (0.3%) had a 5 minutes 
Apgar score (5' Apg) less than 7. About 14.1% required 
admission to the Neonatal Intensive Care Unit (NICU); 
indications included hypoglycaemia, macrosomIa, birth 
asphyxia or neonatal jaundice. All infants were alive at follow ' 
up. The characteristics of study population are summarized in 
tables 4.1-1 and 4.1-2: 
Table 4.1-1 Characteristics of stud 
mean SD / Range / median 
Maternal age (mean, SD) 29.7 5.3 
1 st Stg ( mean, SD): hours 6.4 3.9 
2nd Stg (mean, median): minutes 36.6 25 
Gestational age (mean, SD): days 277.7 8.3 
Birth weight (mean, SD):g 3350 400 
Cord pH( a): mean, range 7.24 7.03 ~ 7.38 
Cord BE(a): mean, range, mmollL -5.28 
-13.3 ~ 1.4 
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Table 4.1-2 Characteristics of stud 
cases percentile 
Primiparas 137 47.4% 
ND 164 56.7% 
VIE 60 20.8% 
emC/S 27 .9.3% 
et C/S 38 13.1% 
MSL 82 28.4% 
CRN 41 4.2% 
Sex (male) 159 55% 
1 minutes Apgar score < 7 16 5.4% 
5 minutes Apgar score < 7 1 0.3% 
NICU admission 41 14.1% 
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4.2 Enzyme reference values in cord blood 
4.2.1 Alanine aminotransferase (ALT, GPT) 
The distribution of AL T in venous cord plasma was 
positively skewed; the mean value of AL T was 9.9 U I L and SD 
was 6.3 U/L. The 950/0 confidence interval of the ALT 
distribution was 2.5 U/L to 22.1 U/L. Figure 4.2-1 shows the 






Mean = 9. 9 UIL 




Figure 4.2-1 Distribution of ALT 
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4.2.2 Aspartate aminotransferase (AST, GOT) 
The distribution of AST in venous cord plasma was 
positively skewed and its mean value was 36.8 U jL, SD is 
20.1 U jL . The 950/0 confidence interval of AST was 18.6 U jL 
to 92.9 U jL. The histogram of the distribution of the AST 
activity in venous cord blood samples is shown in figure 4.2-2. 
c 1 
o 
Mean = 36.8UIL 
SD = 20. lUlL 
N= 289 
10.0 30.0 50.0 70.0 90.0 110.0 130.0 150.0 170.0 190.0 
20.0 40.0 60.0 80.0 100.0 120.0 140.0 160.0 180.0 
AST 
Figure 4.2-2 Distribution of AST 
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4.2.3 Gamma glutamyltransferase (Y-GGT, GGT) 
The distribution of GGT was positively skewed. The 
mean in venous cord plasma was 110.3 U/L and SO was 60.3 
U IL. The 95% confidence interval of GGT in venous cord 
blood plasma was from 28.8 U IL to 266.1 U IL. The 
histogram of the distribution of GGT is shown in figure 4.2-3. 
Figure 4.2-3 Distribution of GGT 
Mean = 110.3 UIL 




4.2.4 Creatine kinase (CK, CPK) 
The mean value of CK in venous cord plasma was 258.8 
U /L with a SO of 112.2 U /L. The 95% confidence interval of 
CK distribution was 109.6 O/L to 513.9 O/L. The histogram of 
the distribution of CK is shown in figure 4.2-4. 
c:: 
Figure 4.2-4 Distribution of CK 
Mean = 258.8 UIL 




4.2.5 Lactate dehydrogenase (LDH) 
The mean activity of the LDH in venous cord plasma 
was 604.0 U/L and SO was 158.7 U/L. The 95% confidence 
interval of LOH distribution was 402.8 U jL to 1038.1 U jL. 





Mean = 604.0 U/L 
SD = 158.7 U/L 
N= 289 
~~~~~~~~~~~~~~~~~ 
'0 '0 '0 '0 ~O '0 '0 '0 '0 ~O l:Qo ~o i:Qo ~o ~o ~o ~o 
LDH 
Figure 4.2-5 Distribution of LDH 
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The statistical distributions of the ALT, AST, GGT, CK 
and LDH were all shown to be positively skewed. If the actual 
values of those five enzymes were transformed to their 
logarithms, the distribution of ALT, GGT, CK, and LDH did 
not differ significantly from Gaussian when tested by the 
Kolgomorov-Smirnov Test (p>O.05), with the exception of AST 
(p<O.05). When AST value was transformed twice (log log 
transformation), the distribution can be accepted as Gaussian 
when tested by the Kolgomorov-Smirnov Test (p>O.05). The 
distribution of those five enzymes and .the 95 percentile range 
is outlined in table 4.2-1. 
Table 4 .2-1 Distribution of five enz mes 
enzymes Mean SD Skew Min Max 95 % confidence 
interval U/L 
ALT 9.9 6.3 5.21 1.2 79.9 2.5 - 22.1 
AST 36.8 20.1 3.66 14.1 190.3 18.6 - 92.9 
GGT 110.3 60.7 0.98 13.1 337.9 28.8 - 266.1 
CK 258 .8 112.2 1.19 58.5 739.4 109.6 - 13 .9 
LDH 604.0 158.7 2.18 51.6 1634.6 402.8 - 1038.1 
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4.3 Changes in fetal enzymes in relation to acid-base 
status at birth 
4.3.1 Correlation between enzymes and arterial cord blood 
gas parameters 
Because of their skewed distribution, the Spearman 
correlation test was applied to test the correlation between 
the enzymes and fetal acid-base status. The result showed 
that AL T, AST and LDH were negatively correlated with 
arterial cord pH and BE. Creatine kinase had a significant 
negative correlation with arterial base excess, but not with 
cord blood pH. Glutamyltransferase was not correlated with 
pH or base excess in arterial cord. Table 4.3-1 summarIZes 
these results and gives the correlation coefficient. 
Table 4.3-1 Correlation between enz mes and fetal acid-base arameters 
pH(a) 
BE(a) 
AL T AST GGT CK LDH 
-0.1210* -0.2800** 0.0171 -0.0820 -0.2631 ** 
-0.1546* -0 .3393** 0.0352 -0.1260* -0.2555** 
Spearman's test * p<O.OS **p<O.001 
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4.3.2 Comparison of fetal enzymes changes in the acidosis 
group and the control group 
The defmition of fetal acidosis in the study was arterial 
cord blood pH ~ 7.15 and the base excess was ~ -8 mmol/L. 
There were 34 cases that met this defmition. Since these five 
enzymes had shown non-Gaussian distribution, a non-
. parametric test (Mann-Whitney U test) for independent 
samples was used for group comparisons. The result showed 
that only AST and LDH activities had significantly higher 
activities in the acidosis group. 
Table 4.3-1 Enz me activities in acidotic rou VS in control rou 
2-tailed p 
mean mean value 
ALT 10.6 (4.0) 9.5 (4.9) NS 
AST 49.0 (36.0) 34.6 (16.1) 0.0005 
y-GGT 104.0 (67.3) 112.0 (60.5) NS 
CK 286.7 (128) 255 .7 (112.3) NS 
LDH 664.0 (128.0) 594.7 (164.8) 0.0002 
Mann-Whitney U test NS = no significant 
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4.4 Changes in fetal enzyme activity in relation to other 
obstetric events 
4.4.1 Changes in fetal enzyme activity ill relation to fetal 
condition and outcome 
1. Correlation with gestational age, birth weight, 1 minute 
and 5 minute Apgar scores 
The results revealed that ALT, AST and LDH were 
positively correlated to gestational age (GA) , but this did not 
apply to CK. GGT was negatively correlated to gestational age. 
For birth weight, significant correlation toALT and GGT were 
detected. AST correlated with 1 minute Apgar scores (1' Apg) 
but not with the 5 minute Apgar scores (5' Apg). LDH 
correlated both with 1 minutes and 5 minutes Apgar score. 
Alanine aminotransferase, GGT and CK were not correlated 
with Apgar scores. These results are shown in Table 4.4-1. 
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Table 4.4~1 Correlation between fetal arameters and fetal enz mes 
ALT AST GGT CK LDH 
G.A 0.1976** 0.1278* -0.2601 ** NS 0.1162* 
Birth weight 0.1284* NS -0.1499* NS NS 
l' Apg NS -0.1458* NS NS -0.2143** 
5' Apg NS NS NS NS -0.1750* 
Spearmann's test NS = no significant *p <0.05 **p < 0.001 
2. Changes in cord blood enzyme activity in the presence of 
meconium-stained liquor 
Eighty-two cases (28.3%) were noted to have meconium-
stained liquor. Only GGT differed significantly between these 
two groups (Mann-Whitney U test), being lower in the 
presence of meconium stained liquor. 
3. Changes in cord blood enzyme activity in the presence of 
nuchal cord 
In this comparIson (Mann-Whitney U test), the 
population was categorized into two groups: presence or 
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absence of nuchal cord, irrespective of the tightness. They 
consisted of 248 cases (85.8%) and 41 cases (14.2%) in each 
group, respectively. No significant differences ill enzymes 
levels were noted between the different groups. 
4. Fetal enzyme activity in relation to sex 
There were 159 (54.6%) male and 130 (45.4%) female 
babies in this study. Of all the enzymes tested, only cord CK 
was significantly higher in males than in females (Mann-
Whitney U-test). Details of the analysis are given "in Table 4.4-
2. 
Table 4.4-2 Enz mes in relation to sex 
ALT AST GGT CK LDH 
Male (UIL) 9.9 38.0 112.6 286.6 615.4 
mean (SD) (7.2) (22.9) (61.8) (126.1) (171.0) 
Female (UIL) 10.0 35.3 107.4 224.8 590.1 
mean (SD) (5.0) (16.0) (59.5) (80.8) (141.5) 
2-tailed p NS NS NS <0.0001 NS 
value 
Mann-Whitney U test NS = no significant 
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4.4.2 Fetal enzyme activity in relation to labor 
The results (Table 4.4-3) showed that AST and LDH were 
positively correlated to the duration of fIrst stage of labor and 
to the duration of second stage of labor; this did not apply to 
AL T and GGT. Creatinine kinase was negatively correlated to 
the duration of the fIrst stage of labor. 
Table 4.4-3 Correlation enz mes and duration of labor 
ALT AST GGT CK LDH 
1 st stage NS 0.1832* NS -0.1510* 0.1943* 
2nd stage NS 0.2948** NS NS 0.2375** 
Spearman's Test NS = no significant *p< 0.05 **p< 0.001 
Fetal enzymes were compared in relation to the mode of 
delivery (Bonferroni test). The results showed that delivery by 
v / E was associated with higher mean values of AST 
compared with ND. The group delivered by el C/S had 
significant lower AST values compared with V /E or emC/S. 
Lactated dehydrogenase had significantly higher mean value 
in V /E group when compared to the el e/s. In contrast, 
significantly lower mean values of GGT were noted in the V /E 
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group than the el CjS group. The result are summarized in 
table 4.4-4: 
Table 4.4-4 Fetal enzymes and mode of delivery. Mean values(U IL). 
ND VIE I em C/S el C/S 
i 
ND NS NS NS NS 
n=164 
............................................... 
VIE AST (VIE vs ND)* NS NS AST (V lE vs el C/S)* 
n=60 43 .9 Vs 35.4 43.9 Vs 27.5 
em C/S NS NS NS AST (em c/s vs el c/s)* 
n=27 42.6 vs 27.5 
............................................... 
el C/S NS GGT (el C/S vs V/E)* NS NS 
n=38 127.0 vs 92.5 
LDH (el C/S vs V lE) * 
543.6 vs 655.0 
Bonferroni's test NS= no significant* p<O.05 
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4.5 Variables related to fetal enzyme levels 
Multiple regression analysis ('enter all' method, p<O.05) 
was applied to fmd out which were the most important factors 
predictive of enzymes levels. The variables used were 
gestational age (GA), duration of first and second stage of 
labor, parity, arterial cord blood pH and base excess, presence 
of nuchal cord or meconium stained liquor, mode of delivery, 
and sex of newborn. It can be concluded that gestational age 
influenced GGT and CK levels, arterial cord blood pH value 
influenced LDH activity, but arterial base excess influenced 
CK only. The presence of meconium stained liquor was related 
to GGT. Duration of fIrst stage of labor influenced CK activity 
in cord blood. Aspartate aminotransferase activities in cord 
blood was affected to the parity, being lower in higher parity. 
Sex of newborn influenced both CK and AST, both enzymes 
showing lower activity in girls. 
Parity and sex of the babies were the most important 
factors affecting AST levels in cord blood. For GGT, the most 
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important factor was gestational age of the fetus, but the 
presence of meconium stained liquor also influenced activity. 
The most important variable affecting CK activity in cord 
blood was the sex of babies, others were gestational age of 
neonate, duration of fIrst stage labor and base excess of 
arterial cord blood. Only arterial cord blood pH was 
significantly related to the level of LDH in cord plasma. In 
contrast, no variables were shown to be predictive of AL T 
activity in cord blood. According to multiple regression 
analysis, those variables can account for 1.5 0/0, 13.2 %, 11.3 
%, 11.5 % and 5.0 % of the variance in AL T, AST, GGT, CK 
and LDH activities in cord blood, respectively. The result of 
these analysis are summarized in Table 4.5-1 to 4.5-5. 
Using weight for gestation as a proxy for antenatal 
growth, and substituting this variable for gestation, mUltiple 
regreSSIon analysis shows that this variable significantly 
influenced AST activity. AL T, GGT, CK, and LDH activities 
were not significantly influenced by variation in weight for 
gestation (Table 4.5-6). 
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Table 4.5-1 Determinants of ALT levels in cord blood. Multiple regression 
analysis. 
Number of cases 289 
R square 0.0626 
Adjusted R Square 0.0155 
Variable coefficient T p value 
BE (a) - 0.0168 -1.678 0.0948 
............... .... ................................................................................... .................................................................................................................. ~ ...................................... ....... ........................................... .. .. ·· ........ · .. i ............ · ............ · .. · .. ·· .. · .. · .................. • ........ · ...... · .. · .. ....................... . 
Nuchal Cord - 0.0334 -0.753 0.4525 
......................................................................................................................................................................................................................... ~ ....................................................................................................... ~ ..................................................................................................... .. 
MSL 0.0458 1.257 0.2099 
.................................................................................................................. ....................................................................................................... ~ ...................................................................................................... + ..................................................................................................... . 
emC/S 0.0324 0.337 0.7364 
............................................................................................................ · .... 1 ............ · ........ · .................... · .. · ........ · .... · ............ · .. .......................... + .................................................................................................... + ...................................................................................................... .. 
GA 0.0029 1.321 0.1879 
..................................................................................................... · .......... ·1 ............ · ...... · .............. · ............ · ........ · .. · ...... · ............ · ...................... -1 ............................................................................................................................................................................................................. .. 
0.0545 0.134 0.8934 
............................................................................................................................................................ .. .................................... ................... .. 1· ...... · .. · .... · .... .......... · .............. · .... · ...... · ...... · .... · .... · .. · ........................ + ...................................................................................................... .. 
Sex 0.0207 0.640 0.5228 
....................................................................................................................................................................................................................... + ........................................................................................................ ~ .............................................................................................. .......... . 
first stage labor 8.356E-0.5 1.053 0.2933 
................................................................................................. · .... · ........ ·1 .. · .... · .... · .............. · .. · .. · ........ · ............................ · .. · .......................... + ........................................................................................................ ! ............................................................................................................ . 
second stage labor - 7.239E-O.4 -1.205 0.2299 
............................................................................................................... ·1 .......... · .. · ...... · .................. · ...... · ............ ·· ...... · ................................... -1 ........................................................................................................ l-............................................................................. ......................... .. 
VIE 0.0094 0.225 0.8226 
................................................................................................................ ·1 ............ · .. · ...... · ...... · ........ · .. · .. · .............. · .............. ·· .......................... + ........................................................................................................ ~ ........................................................................................................... . 
Parity 0.0239 0.637 . 0.5247 
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Table 4.5-2 Determinants of AST levels in cord blood. Multiple regression 
analysis. 
Number of cases 289 
R square 0.1739 
Adjusted R Square 0.1324 
Variable coefficient T p value 
BE (a) - 0.0031 - 1.719 0.0870 
............................................................... ········································ .. ·······1····· ..................................................... ,················ .............. · ............ ·i .............. · .............. · .......................................................................... + .................................................................................................... . 
Nuchal Cord 0.0065 0.806 0.4211 
......................................................................................................................................................................................................................... .; .......................................................................................................... ;. .................... .................................................................................... . 
MSL - 0.0048 - 0.601 0.5483 
................................................................................................................ I .......................... · .............. · .............................................. · ........ .. .. ·4 .............. · .............................................................. · .............. · ......... + ..................................................................................................... . 
em C/S 0.0045 0.257 0.7976 
............................................................................................................................. ........................................................................................... + ........................................................................... .. .............. ... ........ + .................................................................................................... .. 
GA 1. 59292E-04 0.397 0.6915 
................................................................................................................ ·1 ............ · .............. · .............................................. · .............. · ........... + .................................................................................................... + .................................................................................................... . 
- 0.0021 - 0.152 0.8792 
................................................................................................................ I ............................ · .. ·· .......... · ........ ·· .... · ............ .. · .............. ·· · ........... ~ ........................................................................................................ ~ .............................. ................................................. ......................... .. 
Sex - 0.1166 - 1.987 0.0481 
................................................................. .............................................. ·1 .......................................................... · .............. · ............................ + ................................................................... .................................... ~ ....................................................................................................... . 
first stage labor 1.3730£-05 0.955 0.3406 
....................................................................................................................................................................................................................... + .................................................................................................... + ......................... ........................................................................... . 
second stage labor 6.7534E-05 0.620 0.5358 
.. .............................................................................................................. I .................................... ·· .............. ·· .... · .............. ·· ............................ ~ ....................................................................... .............................. + .... .................................................................. .............................. . 
VIE 0.0131 - 1.728 0.0854 
..................... .. ........................................... ······ .... · .. ··· .. ··· ...... ·· ........ ··· .. 1 ....................................................................................................... ., .................................... ................................................................... ~ ............................................................... .. ............................ .. ...... . 
Parity - 0.0142 - 2.096 0.0372 
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Table 4.5-3 Determinants of GGT levels in cord blood. MUltiple 
regression analysis. 
Number of cases 289 
R square 0.1558 
Adjusted R Square 0.1134 
Variable coefficient T p value 
BE (a) - 0.0068 - 0.691 0.4902 
.................................................................. ·· .. · .. ·······································f ········· ... ............... ...................... .............. ········································i············· ......................................................................................... -t ........................................................................................................ . 
Nuchal Cord 0.0330 0.758 0.4494 
.................................................................................................................. ....................................................................................................... ; ......................................................................................................... ,. ...................................................................................................... .. 
MSL - 0.0920 - 2.572 0.0108 
................................................................................................................ ·1 ............ · .............. · .............. · .............. ·· .............. .. · .............. · ............ ~ ......................................................................................................... ~ ....................................................................................................... .. 
emC/S 0.0483 0.513 0.6088 
................................................................................................................ f .......................... · .............. ·· .............................. · .............. · ............. + ...................................................................................................... + ...................................................................................................... .. 
GA 0.0084 - 3.909 0.0001 
................................................................................................................ f .......................... · .............. ·· ................ · .............. · .............. · ............ ·1 ............ ·· .. · .............. · .... · .... · .. · .. .... · .... · .... · .. · .............. · ....................... i-..................................................................................................... . 
PH(a) 0.1180 0.296 0.7675 
Sex - 0.0221 - 0.695 0.4875 
........................................................................................................ · .... · .. ·1 .. · ........................ ·· .............................. · ........ · ............ · ................... + .................................................................................................... + ................................................................. ............ ......................... .. 
first stage labor - 4.7871E-05 - 0.615 0.5391 
........................................................................................................ · ...... ·f ............ · ........ · .......... · ........................ ·· ............ · .. · .......... · ............... + ...................................................................................................... ~ ..................................................................................................... . 
second stage labor 5.4684E-0.4 0.928 0.3545 
......................................................................................................................................................................................................................... .; ............................. ......................................................................... + ..................................................................................................... . 
VIE - 0.0728 - 1.769 0.782 
......................................................................................................................................................................................................................... ; ........................................................................................................ ;. .. ................................................................... ...................................... .. 
Parity 0.0626 1.703 0.900 
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Table 4.5-4 Determinants of CK levels in cord blood. Multiple regression 
analysis. 
Number of cases 289 
R square 0.1569 
Adjusted R Square 0.1146 
Variable coefficient T p value 
BE (a) -0.0162 -2.262 0.0247 
..................... ......................................... ······ .. ························ .. ················1····· .......... ................ .............................. ···········································1········ ·· ............................................................................................ + .............................................................. .................... .. ................... . 
Nuchal Cord 0.1340 0.440 0.6604 
............................................................................................................ ····1················································· ...................................................... ; ...................................................................................................... + ...................................................................................................... . 
MSL -0.0048 -0.185 0.8535 
....................................................................................... ..................... ····1············ ····································· ...................................... ................ ~ .................................................................................................... + .................................................................................................... . 
em C/S 0.0545 0.792 0.4293 
.............•.............................................................................................. ····1············ ····································· .................................................... + ........ .................................................. ............................................. + ................................................ .. .......................... ..... ................... . 
GA 0.0044 2.818 0.0053 
.................................................................•.......................................... ····1······························ ··················· ..................................................... .; ................................................................................ ......................... ;. .................... ................................................................................... . 
0.3328 l.14 0.2540 
...................................•........................................................................ ····1················································· ..................................................... ~ ........... ............................................................................................. ~ ... .............................. ................ ....................................................... . 
Sex -0.0881 -3.802 0.0002 
............................................................................................................ ·····1················································ .......... , .......................................... + ..................................................................................................... + .................................................................................................... .. 
first stage labor -l.4582E-04 -2.567 0.0109 
........................................................................................................ · ...... ·1 ...... · .... · .............. · .. · .......... · ...... · ...... .. .......... · ............ · ........ ............. + ...................................................................................................... + ................................................................................................... .. 
second stage labor -1.8094E-06 -0.420 0.6745 
................................................................................................................ 1 ...................... · .................. .. · ........ .... · ............ · ................................. ~ ....................................... ............................................................... + .................................................................................................... . 
VIE 0.0058 -0.195 0.8457 
..................................................................... .. .......... · .............. ·· .......... ·1 ............ · .... · ...... · .. · .............. · ........................................................... ~ ........................................................................................................ ~ .................................................................................................... .. 
Parity 0.206 0.767 . 0.4437 
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Table 4.5-5 Determinants of LDH levels in cord blood. Multiple 
regression analysis. 
Number of cases 289 
R square 0.0955 
Adjusted R Square 0.0501 
Variable coefficient T p value 
BE (a) 0.1043 0.0916 0.4297 
................................................................................................................. ....................................................... ··, .... ·········· .. ···· .. ·············· .... ····1········ .. ··· ............ ............................................................................... + .......................................... .. .................. , ......................................... .. 
Nuchal Cord 0.9459 0.1056 0.1078 
......................................................................................................................................................................................................................... ~ .. ....................................................................... ............................... ~ ............................................................................................ .. ....... . 
MSL 0.2984 0.0428 0.5355 
......................... ............................. ......... ·· .. ·· .. ··· .... ··· .. ······ .. ··········· .. ········ t · .. ······· ........................... .. ............ ................................................... + ...................................................................................................... + ..................................................................................................... . 
em C/S 0.8181 0.0436 0.5196 
.......................................................................... · .. ·· .... ··· .. ···· .. ··· .. · .... ·· .. ····t .. · .. ··· .. · ...... ·· .... ···· .. · ......................................................................... !, ................................... .. ................................................................. + ...................................................................................................... .. 
GA -0.0058 -0 .0135 0.8423 
............................................................................. ·· .. ·· .. ·· .. ··· .. ...... .. .. · .. .. ···t ...... ···· .... ·· .. · .... · .... ·· .. ···· .. ··· ............................................................ + ....................................................................................................... ; ........................................................................................................ . 
-12.1889 -0.2628 0.0239 
................................................................................................................. ......................................................... , ............................... ............ + ..................................................................................................... + ......................................................................................................... . 
Sex -0 .4583 -0.0707 0.2842 
................................................................................................................. ................................ ....................................... ............................... + ............................................................................ ..... ....................... ~ ............................... .. .. ............ , .... .. ......... ............. .................... ...... .. 
first stage labor 0.0017 0.1208 0.1140 
...................................... .................... ·············· .... ··········· .. ··· .. ·· .. ········ .. ····t .. ···· ........... .................. ................................................................... + ........................................................................................................ , ..................................................................................................... .. 
second stage labor 0.0010 0.0106 0.8976 
................................................................. ······· .. ············ .... ······· .. ·· .. ····· .. ··t .. ··· .. ··· .... ·· ....................................................................................... -1 ....................................................................................................... ; .... , .............................................................................................. .......... . 
VIE 0.8356 0.1140 0.1323 
................................................................. ··· .. ··· .... · .. ·· .. ··· .. ·· .. ···· .. ····· .. ··· .... 1 .. ········· ...... · .. · ............. .. .................................................................. ~ ....................................................................................................... ~ ...................................................................................................... .. 
Parity -0.0167 -0 .0026 0.9730 
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Table 4.5-6 Determinants of AST levels in cord blood (weight for 
gestation substituted for gestation) . Multiple regression analysis. 
Number of cases 289 
R square 0 .1739 
Adjusted R Square 0.1324 
Variable coefficient T p value 
BE (a) -2 .1E-03 - 1.252 0 .212 
................................................................................................................. ........... , •••••• , .................................................................................. -1 ............. , .......................................................................................... + ...................................................................................................... . 
Nuchal Cord -2 .7E-04 -0 .055 0 .956 
................................................................................................................. ......................................................... , ............... , .............................. '; ................................................................................. ..................... 1' ............ ............................................ , .............................. , .. ............ .. 
MSL - 7.8E-04 - 0.254 0 .800 
................................................................................................................. ...................................................................................................... ·i ............ · .............. · .............. · ............ .. · ............ · .. , .............. , ............... ~ ........................................................ , ..... .. ...................................... . 
em C/S 1. 148E-02 0.564 0.514 
................................................................................................................. ........................................................................ , ................. · ...... · ...... i· .... · .... · .......... · .......... · ................ · ........ · .... · ........ · .............. , ........ · ...... i· ...... · .......... · ................ · .. · .... · .... · .. · .... · .. , .. · .. · ...................................... . 
-8.1E-02 -1.354 0.177 
........................................................................................................................................................................................................................ ·'1 .. · ............ · .......................... · .............. · ........ · ........ · ........................... 1' ............................... .. ....................................... , ............................. .. 
. Sex -1.4E-02 -2 .284 0.032 
................................................................................................................. .......................................... , .............................................................. '; ............................................................................... · ............ · ...... · .. 'r ...... · ........ · .................... · .... ·, .... · ...... · .. · ...... · ...................................... . 
first stage labor 2 .037E-05 1.430 0 .154 
................................................................................................. .... .......... ·1 .... · .... · ...... · ................ · .............. · ............ · .. .... .. .......... · .. · .. · ..... ......... ;, ................................................ .. ........................ , .............. , .............. ; .. ..... ......................................................... .. ...................................... . 
second stage labor 1.054E-04 0.964 0 .336 
...................................................................................... .. ................... · .... 1 ........ · .. · ...... · .......... · .. · .... · ...... · ........ · .. · .......... · .... · ............................ ··1 ............................ • .. • .......................... • .... • .......... • .. ...... • .. • .. ........ • .... i .. · ................ · ........................ , .............. · .............. ·, ........................... .. 
VIE 1.571E-02 2 .085 0.038 
............................................................................................................. · .. 1· ........ · .. .. .... · .................... · ................ · .. · .. · .... · .................. · .............. <, ......................................................................................... , ..... ........ ; ........................................... .............. ... ..... ..... ........... ........ , ............ .. . 
Parity -1.7E-03 -0.410 0 .682 
........................................................... ..... ................................................ 1 .... · ...... · .. · ............ ·· .. · .... .. · ............ · .... · .... ......................................... ~ ..................................................................................................... + ............ ....................................................................................... .. 




5.1 Reference values for cardiac and liver enzymes in cord 
blood for current study population 
According table 4. 1- 1 and table 4.1-2, the 
characteristics of the study population representative of the 
general population in our unit, with most women at low risk. 
The 95 % confidence intervals for all the cord blood enzymes 
tested are in agreement with one previous report (Kristensen 
et al, 1979). The range of values suggest that AST, GGT, CK 
and LDH are higher in the fetus than in adults. It also 
confIrms the results reported by others (Perkins et al, 1993 
and Lackmann et al, 1996). 
The increased GGT activity in the neonate (Walker et al, 
1974; Davidson, 1976 Garcia et al, 1987), one possible reason 
may be related to hepatic immaturity. Garcia and colleagues 
(1987) suggested that GGT declined in neonatal serum until 
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reaching adult levels seven months after delivery (Knight et 
al, 1981). This is paralleled by a similar decline in serum a-
fetoprotein levels (Wu et al, 1981). 
Several authors have reported that creatine kinase 
continues to peak 8 to 24 hours post-partum (Gilboa et al, 
1976; Jouppila et al, 1978; Jedeikin et al, 1982 and Liras et 
al, 1988). The higher level in early infancy has been partially 
attributed to the trauma of childbirth (Gilboa et al, 1976 and 
Jouppila et al, 1978). 
The interpretation of the higher LDH values is difficult 
in the absence of LDH isoenzymes determination in our study 
but the elevation might be of hemolytic origin as well as due 
to anoxia (Blum et al, 1975 ). 
Alanine aminotransferase in cord blood was lower in the 
current study than in healthy adults, confIrming the fmdings 
of King (1961) and Blum (1975). The latter demonstrated 
lower levels of ALT in preterm compared to term infants and 
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suggested that lower levels of AL T may be due to immaturity 
of enzyme synthesis in the liver. 
5.2 Changes in fetal enzyme activity in relation to fetal acid-
base status 
Our fmdings suggest that a relationship exists between 
fetal cord blood enzymes and acid-base parameters. This 
correlation was noted for alanine aminotransferase, aspartate 
aminotransferase, creatine kinase and lactate dehydrogenase 
(Table 4.3-1 ). Aspartate aminotransferase and lactate 
dehydrogenase showed the strongest correlation with pH and 
base excess, whereas GGT was not correlated. Creatine kinase 
was negatively correlated with the cord blood base excess but 
not with pH values. 
The lack of correlation between fetal acid-base status 
parameters and y-glutamyltransferase in our popUlation is at 
variance with previous work. In a study (Bartnicki et al, 
1989) of two hundred and thirty one cases, undergoing 
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measurement of GGT levels in umbilical arterial blood, the 
levels were normal «80 IU IL) in 76% of the neonates born to 
mothers with normal placental function. In 63% of the 
mothers with placental insufficiency the GGT levels were 
found to be above 80 IV I L. Increased enzyme levels were also 
associated with decreased pH in the umbilical artery. This 
author suggested that placental dysfunction caused chronic 
hypoxia and this in turn induced fetal liver cell damage that 
resulted in increased GGT activity. In their study, the 
population consisted of obstetric patients at a gestation of 37 
weeks, whereas in ours the mean gestational age was 39.7. 
Since the other patient characteristics were not given, a valid 
comparison of the data cannot be made. 
We believe that the poor correlation of GGT with fetal 
acid-base status may be due to the very small number of 
infants with significant birth asphyxia in our study. The 
extent of hypoxic cell damage in our study population was too 
low to cause extensive cell death with subsequent release of 
cell membrane-bound enzymes. 
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Creatine kinase was significantly correlated to the base 
excess but not with pH values; this was also demonstrated by 
Hollander (1987). They suggested that hypoxia and/or 
asphyxia leads to anaerobic metabolism and lactic acidosis. 
Acid-base balance may change rapidly in response to the 
changes in pC02 values but base excess reflects a damped or 
conservative picture of the magnitude of the metabolic 
changes from normal; changing only if affected by prolonged 
hypoxia. 
In conjunction with the rIse ill enzyme activity (AL T, 
AST, CK and LDH) is a lowering of cord blood pH value and/ or 
base excess which probably indicate that hypoxic damage has 
occurred. These increases are presumed to result from 
ischaemia-induced leakage of enzymes from damaged cells. 
In our study, only aspartate aminotransferase and 
lactate dehydrogenase were shown to be statistically higher 
in the acidosis group than in controls. The absence of 
significant differences in CK in the current study confirm the 
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preVIOUS finding by Niklinski and his colleagues (1989). In 
their study, it was shown that total creatine kinase and 
muscle-type creatine kinase were no higher in the hypoxia 
group than in the control group, but brain type creatine 
kinase was significantly higher . They suggest that skeletal 
muscle is less vulnerable to hypoxic damage whereas fetal 
brain is more vulnerable to hypoxic damage. 
The fact that AST and LDH correlate with fetal acid:-
base status and demonstrate higher activity in the acidosis 
group suggests that their release may be an early response to 
intrapartum hypoxia and acidosis. The pattern of enzyme 
correlation with acid-base parameters does not conform with 
the classic descriptions of hepatic or cardiac hypoxic injury 
and may arise from damage to more than one organ system 
since LDH is a Ubiquitous enzyme. The close correlation 
between lactate dehydrogenase and aspartate 
aminotransferase (R=O.5818) suggests that these enzymes 
were released most probably from same mechanism or from 
the same organ system. Changes in these enzymes may be 
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potentially sensitive indicators of cellular injury resulting from 
intrapartum asphyxia. 
5.3 Changes in fetal enzyme activity ID relation to other 
obstetric variables 
Our results have shown that aspartate 
. aminotransferase, and lactate dehydrogenase were 
significantly and positively correlated with the duration of first 
and second stages of labor, especially with the latter. These 
two enzymes were also related to the mode of delivery. Both 
had significantly lower mean values in the elective cesarean 
section group but higher levels following vacuum extraction 
delivery (V / E). The indications for V / E in our unit are 
prolonged second stage of labour, and suspected fetal distress 
as shown by an abnormal fetal heart rate pattern in the 
second stage of labour. One third of cases in this group were 
due to suspected fetal distress, others due to prolonged 
second stage of labour. 
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Delivery per se, implying trauma or hypoxia, may 
influence enzyme levels. The higher levels of AST and LDH in 
this group may be due to birth trauma and "fetal stress". 
Hematoma associated with vacuum extraction may be 
followed by a small amount of hemolysis with consequentrise 
in LDH. 
We cannot explain the negative correlation between 
creatine kinase and duration of first stage labor. It is probably 
due to a random effect. Another interesting fmding in the 
study is that only creatine kinase was shown to be 
significantly different between the sexes. It had a higher mean 
value in male babies than female infants (p<O.OOOl). This is in 
conflict with data from Perkin and colleagues (1993) who 
reported that AL T, AST, GGT, CK and LDH were not 
statistically related to sex bias in cord blood. Other authors 
(Lackmann et al, 1996 and Sutton et al, 1981) have reported 
that creatine kinase activity was not significantly different 
between the sexes. 
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Racial differences in creatine kinase values have been 
reported in adults (Meltzer et al , 1974). It may be that in the 
chinese population sex differences are more prominent. 
Additional studies would be necessary to clarify this point. 
In the current study, glutamyltransferase was shown to 
be significantly correlated with gestational age (R=-O.260 
p<O.OO 1) and weakly correlated with birth weight. Rivera and 
colleagues (1990) measured glutamyltransferase activity in 
cord blood of 125 samples of 24 to 42 weeks of gestation. A 
separate study (Hallak et al, 1994) evaluated 72 cord blood 
samples by cordocentesis in a popUlation affected by fetal 
malformations, red blood cell alloimm unization, 
oligohydramnios, immunologic thrombocytopenic purpura 
and possible fetal infection. Both of them reported no 
significant correlation between gestational age and GGT 
existed. This was possibly not detected in their studies 
because of sample size or high risk study populations. 
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No correlation was shown in our study between GGT 
and Apgar scores, confIrming previous reports (Shore et al 
1974, Rivera et al 1990). Glutamyltransferase was shown to 
be significantly lower in the presence of meconium stained 
liquor, but this did not apply to other enzymes. Similarly, GGT 
levels in cord blood were significant lower in the vacuum 
extraction delivery group when compared to elective cesarean 
. sections. Our data also showed that the mean gestational age 
was higher in the presence of meconium stained liquor 
(p<O.OOO 1) and for babies delivered by vacuum extraction 
delivery (p<O.OS). 
5.4 Analysis of inter-relationships between obstetric 
variables and fetal enzymes 
We used mUltiple regreSSIon analysis to explore the 
inter-relationships between obstetric variables and fetal 
enzymes. Among the variables we studied, the most 
significant correlation was between aspartate 
aminotransferase activities in cord blood, sex of neonate and 
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parity. These variables can only explain 13% of the variation 
in AST. It could possibly be related to the effects of labour 
and delivery due to physical trauma and the degree of fetal 
hypoxia. It is known that primiparas have a longer duration 
of labour; this may increase the chance of fetal hypoxia and 
birth trauma by increasing the duration of labor. 
For creatine kinase, the relationship was statistically 
valid between arterial base excess, gestational age, sex of the 
newborn and duration of the fIrst stage of labor. These 
variables could explain 11 % of the variation in CK. According 
to this result, the rise of CK level in cord blood can be 
attributed to fetal hypoxia and birth trauma too. 
The studies of the perinatal mortality rate in comparable 
male and female infants have shown that female infants 
usually have a survival advantage over males (Khoury et al, 
1985; Re snick, 1989 and Hoffman et al, 1990). Our results 
have shown that male babies have higher AST and CK levels 
in cord blood. This suggests that the male baby is either more 
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vulnerable to hypoxic damage, or hypoxia IS more likely to 
occur. 
The significant correlation between lactate 
dehydrogenase and pH value in cord blood was confirmed by 
multiple regression analysis. However, the pH could only 
explain 5 % of the changes of LDH levels in umbilical cord, 
. suggesting that acidosis has only a weak effect on this enzyme 
level. 
Glutamyltransferase activity in cord blood seems to be 
correlated with indices of fetal maturity such as gestational 
age and the presence of meconium stained liquor. About 140/0 
of the variation in GGT can be explained by these two factors. 
Our data suggests that the presence of meconium is more 
likely to be related to gestational age since GGT shows no 
correlation with fetal acid-base parameter and Apgar scores. 
Summary: The result of this thesis show that a relationship 
exists between cord blood enzyme concentration and acid-
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base parameters. Such results support the hypothesis that 
fetal hypoxia causes changes in the permeability of cell 
membranes resulting in the release of the enzymes into the 
blood circulation. 
Future research areas may include correlation of 
enzyme activity with lipid peroxide concentration ( as 
footprints of free oxygen radical activity ), and purine 
degradation products such as hypoxanthine and xanthine as 
measures of hypoxia. 
Isoenzymes of CK may also be assayed in order to 
explored the specific organs affected by fetal hypoxia. 
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